Related Experiment Videos

Embolization as treatment of choice for bleeding peptic ulcers in high-risk patients

Raoul van Vugt1, Koop Bosscha, Ivo P van Munster

  • 1Department of Surgery, Jeroen Bosch Hospital, Location Groot Ziekengasthuis, Nieuwstraat 34, 's-Hertogenbosch, The Netherlands. raoul.vanvugt@gmail.com

Digestive Surgery
|January 22, 2009
PubMed

Insights

Embolization effectively treated bleeding peptic ulcers in high-risk patients when endoscopic methods failed. This minimally invasive procedure offered a successful alternative to surgery, improving outcomes for patients with acute upper gastrointestinal bleeding.

Area of Science:

  • Interventional Radiology
  • Gastroenterology
  • Vascular Surgery

Background:

  • Peptic ulcers are a leading cause of acute upper gastrointestinal bleeding.
  • Many patients with bleeding peptic ulcers are unsuitable for surgery.
  • Endoscopic treatment failure necessitates alternative interventions.

Purpose of the Study:

  • To evaluate the efficacy of embolization for bleeding peptic ulcers in high-risk patients.
  • To assess embolization as a treatment of choice after endoscopic failure.
  • To describe the clinical course and outcomes of embolization in this patient group.

Main Methods:

  • Retrospective descriptive study of 16 patients undergoing selective arterial embolization (superior mesenteric and/or gastroduodenal arteries).
  • Analysis of risk factors for surgery and mortality.
  • Evaluation of primary technical success and clinical success rates.
  • Assessment of 30-day mortality.

Main Results:

  • Clinical success rate was 81% (13/16 patients).
  • Primary technical success (bleeding control) was 88% (14/16 patients).
  • 30-day mortality was 37.5% (6/16 patients), primarily due to non-embolization-related complications.

Conclusions:

  • Embolization is a successful, minimally invasive alternative to surgery for bleeding peptic ulcers in high-risk patients.
  • It provides an effective treatment option when endoscopic interventions fail.
  • The procedure demonstrates significant efficacy in controlling acute upper gastrointestinal bleeding.
Abstract

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease